Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $83.84 | 5 | 84.9% |
| Education | $14.90 | 1 | 15.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $62.70 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $21.14 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.90 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.04 | 1 | Novo Nordisk Inc ($20.04) |
| 2020 | $16.37 | 1 | Novo Nordisk Inc ($16.37) |
| 2019 | $41.19 | 3 | Novo Nordisk Inc ($26.29) |
| 2017 | $21.14 | 1 | GlaxoSmithKline, LLC. ($21.14) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Obesity | ||||||
| 03/04/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.37 | General |
| 10/08/2019 | Novo Nordisk Inc | Levemir (Drug), NovoLog, NovoLog Mix 70/30 | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Diabetes | ||||||
| 08/01/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2019 | Novo Nordisk Inc | Levemir (Drug), NovoLog, NovoLog Mix 70/30 | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Diabetes | ||||||
| 01/23/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 12 | 13 | $260.00 | $59.30 |
| 2020 | 1 | 17 | 17 | $340.86 | $98.73 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2021 | 12 | 13 | $260.00 | $59.30 | 22.8% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2020 | 17 | 17 | $340.86 | $98.73 | 29.0% |
About Dr. Damien Chong-Hanssen, M.D
Dr. Damien Chong-Hanssen, M.D is a Family Medicine healthcare provider based in Waimea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2009. The National Provider Identifier (NPI) number assigned to this provider is 1114152501.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Damien Chong-Hanssen, M.D has received a total of $98.74 in payments from pharmaceutical and medical device companies, with $20.04 received in 2024. These payments were reported across 6 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($83.84).
As a Medicare-enrolled provider, Chong-Hanssen has provided services to 29 Medicare beneficiaries, totaling 30 services with total Medicare billing of $158.03. Data is available for 2 years (2020–2021), covering 2 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Waimea, HI
- Active Since 05/28/2009
- Last Updated 02/16/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114152501
Products in Payments
- Levemir (Drug) $26.29
- ADVAIR (Drug) $21.14
- Wegovy (Drug) $20.04
- SPIRIVA RESPIMAT (Drug) $14.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.